Package 0069-5629-05

Brand: doxorubicin hydrochloride

Generic: doxorubicin hydrochloride
NDC Package

Package Facts

Identity

Package NDC 0069-5629-05
Digits Only 0069562905
Product NDC 0069-5629
Product ID 0069-5629_d31d7f58-66d0-4826-b6b5-5914c031965f
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (0069-5629-05) / 5 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2025-03-31
Brand doxorubicin hydrochloride
Generic doxorubicin hydrochloride
Sample Package No

Linked Drug Pages (1)

Doxorubicin Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "d31d7f58-66d0-4826-b6b5-5914c031965f", "openfda": {"unii": ["82F2G7BL4E"], "rxcui": ["1790097", "1790099"], "spl_set_id": ["d31d7f58-66d0-4826-b6b5-5914c031965f"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0069-5629-05)  / 5 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "0069-5629-05", "marketing_start_date": "20250331"}], "brand_name": "Doxorubicin Hydrochloride", "product_id": "0069-5629_d31d7f58-66d0-4826-b6b5-5914c031965f", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Anthracycline Topoisomerase Inhibitor [EPC]", "Anthracyclines [CS]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "0069-5629", "generic_name": "Doxorubicin Hydrochloride", "labeler_name": "Pfizer Laboratories Div Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Doxorubicin Hydrochloride", "active_ingredients": [{"name": "DOXORUBICIN HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "NDA050629", "marketing_category": "NDA", "marketing_start_date": "20250331", "listing_expiration_date": "20261231"}